PF-Atlas › Mechanisms › EV cargo (miR-29, let-7d) delivers anti-fibrotic miRNA without cell engraftment risk
EV cargo (miR-29, let-7d) delivers anti-fibrotic miRNA without cell engraftment risk in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
EV cargo (miR-29, let-7d) delivers anti-fibrotic miRNA without cell engraftment risk is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting EV cargo (miR-29, let-7d) delivers anti-fibrotic miRNA without cell engraftment risk
Therapies
Medical disclaimer. This is a research summary, not medical advice.